These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18698520)

  • 1. Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study.
    McAllister TW; Flashman LA; Harker Rhodes C; Tyler AL; Moore JH; Saykin AJ; McDonald BC; Tosteson TD; Tsongalis GJ
    Brain Inj; 2008 Aug; 22(9):705-14. PubMed ID: 18698520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistatic effect of Ankyrin repeat and kinase domain containing 1 - Dopamine receptor D2 and catechol-o-methyltransferase single nucleotide polymorphisms on the risk for hazardous use of alcohol in Lithuanian population.
    Kaminskaite M; Jokubka R; Janaviciute J; Lelyte I; Sinkariova L; Pranckeviciene A; Borutaite V; Bunevicius A
    Gene; 2021 Jan; 765():145107. PubMed ID: 32889058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttraumatic Brain Injury Cognitive Performance Is Moderated by Variation Within ANKK1 and DRD2 Genes.
    Failla MD; Myrga JM; Ricker JH; Dixon CE; Conley YP; Wagner AK
    J Head Trauma Rehabil; 2015; 30(6):E54-66. PubMed ID: 25931179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a common genetic variant within ANKK1 with six-month cognitive performance after traumatic brain injury.
    Yue JK; Pronger AM; Ferguson AR; Temkin NR; Sharma S; Rosand J; Sorani MD; McAllister TW; Barber J; Winkler EA; Burchard EG; Hu D; Lingsma HF; Cooper SR; Puccio AM; Okonkwo DO; Diaz-Arrastia R; Manley GT; ;
    Neurogenetics; 2015 Jul; 16(3):169-80. PubMed ID: 25633559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DRD2 C957T polymorphism is associated with improved 6-month verbal learning following traumatic brain injury.
    Yue JK; Winkler EA; Rick JW; Burke JF; McAllister TW; Oh SS; Burchard EG; Hu D; Rosand J; Temkin NR; Korley FK; Sorani MD; Ferguson AR; Lingsma HF; Sharma S; Robinson CK; Yuh EL; Tarapore PE; Wang KK; Puccio AM; Mukherjee P; Diaz-Arrastia R; Gordon WA; Valadka AB; Okonkwo DO; Manley GT;
    Neurogenetics; 2017 Jan; 18(1):29-38. PubMed ID: 27826691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes.
    Dubertret C; Bardel C; Ramoz N; Martin PM; Deybach JC; Adès J; Gorwood P; Gouya L
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):492-9. PubMed ID: 20138949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the Association of D2 Dopamine Receptor Gene and Reported Allele Frequencies With Alcohol Use Disorders: A Systematic Review and Meta-analysis.
    Jung Y; Montel RA; Shen PH; Mash DC; Goldman D
    JAMA Netw Open; 2019 Nov; 2(11):e1914940. PubMed ID: 31702801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the dopamine D2 receptor T allele on response latency after mild traumatic brain injury.
    McAllister TW; Rhodes CH; Flashman LA; McDonald BC; Belloni D; Saykin AJ
    Am J Psychiatry; 2005 Sep; 162(9):1749-51. PubMed ID: 16135640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 35.8 kilobases haplotype spanning ANKK1 and DRD2 is associated with heroin dependence in Han Chinese males.
    Zhang J; Yan P; Li Y; Cai X; Yang Z; Miao X; Chen B; Li S; Dang W; Jia W; Zhu Y
    Brain Res; 2018 Jun; 1688():54-64. PubMed ID: 29550268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic diversity of the North African population revealed by the typing of SNPs in the DRD2/ANKK1 genomic region.
    Mestiri S; Boussetta S; Pakstis AJ; Elkamel S; Elgaaied ABA; Kidd KK; Cherni L
    Gene; 2021 Apr; 777():145466. PubMed ID: 33524518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol.
    Giegling I; Balzarro B; Porcelli S; Schäfer M; Hartmann AM; Friedl M; Konte B; Krämer P; Möller HJ; De Ronchi D; Stassen HH; Serretti A; Rujescu D
    Eur Arch Psychiatry Clin Neurosci; 2013 Feb; 263(1):65-74. PubMed ID: 22893251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility.
    Ghosh J; Pradhan S; Mittal B
    Neuromolecular Med; 2013 Mar; 15(1):61-73. PubMed ID: 22875483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1.
    Dick DM; Wang JC; Plunkett J; Aliev F; Hinrichs A; Bertelsen S; Budde JP; Goldstein EL; Kaplan D; Edenberg HJ; Nurnberger J; Hesselbrock V; Schuckit M; Kuperman S; Tischfield J; Porjesz B; Begleiter H; Bierut LJ; Goate A
    Alcohol Clin Exp Res; 2007 Oct; 31(10):1645-53. PubMed ID: 17850642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems.
    Meyers JL; Nyman E; Loukola A; Rose RJ; Kaprio J; Dick DM
    Addict Biol; 2013 May; 18(3):523-36. PubMed ID: 22970887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample.
    Huang W; Payne TJ; Ma JZ; Beuten J; Dupont RT; Inohara N; Li MD
    Neuropsychopharmacology; 2009 Jan; 34(2):319-30. PubMed ID: 18354387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DRD2 and ANKK1 genes associate with late-onset heroin dependence in men.
    Tsou CC; Chou HW; Ho PS; Kuo SC; Chen CY; Huang CC; Liang CS; Lu RB; Huang SY
    World J Biol Psychiatry; 2019 Oct; 20(8):605-615. PubMed ID: 28854834
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of DRD2 and ANKK1 genotypes on apomorphine-induced growth hormone (GH) response in alcohol-dependent patients.
    Lucht M; Samochowiec A; Samochowiec J; Jasiewicz A; Grabe HJ; Geissler I; Rimmbach C; Rosskopf D; Grzywacz A; Wysiecka JP; Tybura P; Brzuchalski B; Bieńkowski P
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):45-9. PubMed ID: 19796663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence.
    Vereczkei A; Demetrovics Z; Szekely A; Sarkozy P; Antal P; Szilagyi A; Sasvari-Szekely M; Barta C
    PLoS One; 2013; 8(6):e66592. PubMed ID: 23840506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between ANKK1 (rs1800497) polymorphism of DRD2 gene and attention deficit hyperactivity disorder: a meta-analysis.
    Pan YQ; Qiao L; Xue XD; Fu JH
    Neurosci Lett; 2015 Mar; 590():101-5. PubMed ID: 25641135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
    Doehring A; Hentig Nv; Graff J; Salamat S; Schmidt M; Geisslinger G; Harder S; Lötsch J
    Pharmacogenet Genomics; 2009 Jun; 19(6):407-14. PubMed ID: 19373123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.